Added to YB: 2024-05-15
Pitch date: 2024-05-14
PODD [bearish]
Insulet Corporation
-69.7%
current return
Author Info
No bio for this author
Company Info
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally.
Market Cap
$23.4B
Pitch Price
$174.25
Price Target
136.87 (-54%)
Dividend
N/A
EV/EBITDA
45.88
P/E
96.41
EV/Sales
9.41
Sector
Health Care Equipment and Supplies
Category
special_situation
Blue Orca is Short Insulet Corporation (NASDAQ: PODD)
PODD: Blue Orca short as appeals court killed injunction protecting monopoly vs EOFlow, clearing path for acquisition & shattering US tubeless AID monopoly. Insulet failed to disclose defeat despite prior disclosure of win. 15%+ share price drop expected as competition returns.
Read full article (1 min)